We’ve been alerted to a third retracted paper, and a retracted book chapter, for Stefano Ramello, a self-styled “independent researcher” into sexual identity.
Turns out there wasn’t so much independence after all.
Add to the retraction pile for a pair of chemists in Iran who duplicated their work — and reviewed their own articles to boot.
The authors, Kobra Pourabdollah and Bahram Mokhtari, are affiliated with the Razi Chemistry Research Center in the Shahreza Branch of Islamic Azad University. In September, we reported on the retractions of three articles by the researchers in Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry.
Readers then alerted us to five other retractions in the Journal of Coordination Chemistry — although these papers did not appear (at least by the retraction notice) to have involved self-reviewing.
A group at the University of Texas Southwestern that retracted five papers last year has retracted one more, and has had a paper subjected to an Expression of Concern at the request of the school’s dean.
A pair of engineering researchers has analyzed the work of a handful of prolific scientific fraudsters, and has concluded that science needs a “shame list” to deter future misconduct.
We’ve found a third retraction for Karel Bezouška, the Czech scientist, who, as we reported this summer, broke into a lab in an attempt to tamper with experiments trying to replicate his own falsified data.
The article, “Molecular Characterization of Binding of Calcium and Carbohydrates by an Early Activation Antigen of Lymphocytes CD69,” had appeared in 2003 in Biochemistry. and has been cited 29 times, according to Thomson Scientific’s Web of Knowledge.
The Journal of Neuroscience has retracted a 2011 paper by a group of UCLA researchers after the institution concluded that a post-doc at the institution had falsified data.
The article, “Epigenetic Enhancement of BDNF Signaling Rescues Synaptic Plasticity in Aging,” came from the lab of Cui-Wei “Tracy” Xie, a behavioral scientist. It has been cited 42 times, according to Thomson Scientific’s Web of Knowledge.
Carcinogenesis has the publishing world’s version of a twin problem: two dysfunctional articles yet one gets retracted while the other merely suffers a correction. Is it nature — or nurture?
The authors of a 2008 study purporting to explain how the herbicide atrazine acts on cancer cells have asked the journal that published it to retract it for “inadvertent errors,” Retraction Watch has learned.
By now, Retraction Watch readers may have heard about new Nobel laureate Randy Schekman’s pledge to boycott Cell, Nature, and Science — sometimes referred to the “glamour journals” — because they damage and distort science. Schekman has used the bully pulpit of the Nobels to spark a conversation that science dearly needs to have about the cult of the impact factor.
The argument isn’t airtight. Schekman — now editor of eLife, an open access journal — says that open access journals are a better way to go, although he doesn’t really connect mode of publishing with the quality of what’s published. Others have pointed out that the move will punish junior members of his lab while likely having no effect on the career of someone who has published dozens of studies in the three journals he’s criticizing, and has, well, won a Nobel.